Yuichiro Ohe

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Yuichiro Ohe

Apr 6, 2025, 05:33 | Blog

Hidehito Horinouchi: Taletrectinib in ROS1 plus Non–Small Cell Lung Cancer

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared on X about a recent…

Jan 3, 2025, 16:25 | Science

Amivantamab Plus Lazertinib in Patients With EGFR-mutant NSCLC by Benjamin Besse et al.

A recent article by Benjamin Besse et al. was mentioned by Akhil Santhosh, Medical Oncology Specialist at…

Oct 16, 2024, 18:00 | Insight

Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?

Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…

Aug 13, 2024, 20:25 | Insight

Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023